Institution
Complejo Hospitalario de Navarra
Also known as: CHN
- 20running trials
- 21closed trials
- 6,641publications (OpenAlex)
Running trials
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Recruiting
Active, not recruiting
Recruiting
Study of Personalized Allocation of Defibrillators in Non-ischemic Heart Failure (SPANISH-1)
Recruiting
Recruiting
NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults
Active, not recruiting
Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years
Active, not recruiting
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
Recruiting
Recruiting
Recruiting
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Recruiting
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Bladder cancer2 recruiting
- Obesity2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Cerebral palsy1 recruiting
- Childhood cancers1 recruiting
- Colorectal cancer1 recruiting
- Crohn's disease1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Dilated cardiomyopathy1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Heart failure1 recruiting
- Huntington's disease1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL
Completed
Completed
Terminated
Completed
Follow-up in Early and Locally Advanced Breast Cancer Patients
Completed
First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC
Completed
Completed
Completed
Completed
Completed
TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"
Completed
Completed
Completed
Completed
Completed
Completed
Registry name variants (9)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Complejo Hospitalario de Navarra
Pamplona, Iruña 31008
40 trials
Complejo Hospitalario de Navarra
Pamplona, Navarre 31008
1 trial
Complejo Hospitalario Navarra
Pamplona
1 trial
NCT04179929Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults
Contact: M Carmen Mateos
Complejo Hospitalario de Navarra (CHN)
Pamplona, Pamplona 37008
Complejo Hospitalario de Navarra - Nefrologia
Pamplona, Navarre 31008
Complejo Hospitalario de Navarra (Pamplona)
Pamplona, Navarre 31008
COMPLEJO HOSPITALARIO DE NAVARRA;Servicio de Hematología
Pamplona, Navarre 31008
COMPLEJO HOSPITALARIO DE NAVARRA (Site 1302)
Pamplona, Navarre 31009
COMPLEJO HOSPITALARIO DE NAVARRA (Site 2407)
Pamplona, Navarre 31009
Conditions
Diseases this institution publishes on or runs trials for.
- Giant cell arteritis3 works · 0 trials
Institution data: ROR 011787436 (CC0-1.0)Updated 15 Nov 2026